SCANEX MEDICAL SYSTEMS A/S: Financial statements 2019
CVR: 16278394
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
SCANEX MEDICAL SYSTEMS A/S (CVR 16278394) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 6,144,291 and a net result of DKK 2,344,220 compared with DKK 1,344,145 the year before. That is an increase of 35.9% compared with the year before. Equity in the 2019 report amounted to DKK 5,921,911. The solvency ratio was 35%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 6,144,291
- Profit/Loss
- DKK 2,344,220
- Equity
- DKK 5,921,911
- Total Assets
- DKK 16,911,198
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 6.1M | 2.3M | 5.9M | 5 |
| 2018 | - | 4.5M | 1.3M | 4M | 5 |
| 2017 | - | 4M | 700K | 3.2M | 5 |
| 2016 | - | 3.3M | 391K | 2.5M | 5 |
| 2015 | - | 3.1M | 245K | 2.1M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
SCANEX MEDICAL SYSTEMS A/S has published its annual report for 2018. Gross profit came to DKK 4,521,571, and the net result was DKK 1,344,145.
About SCANEX MEDICAL SYSTEMS A/S
SCANEX MEDICAL SYSTEMS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1992. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named PC MEDICAL A/S and A/S PSE NR. 4663. The management consists of Sune Schmølker. The board consists of Finn Otto Enbom Madsen (chair), Elisabeth Enbom Madsen and Sune Schmølker. The company is owned by Scanex Medical Nordics ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 10,254,852 and a net result of DKK 2,630,439 compared with DKK 1,705,649 the year before. Equity in the 2025 report amounted to DKK 20,121,634.
